EQS-News: Vossloh Aktiengesellschaft / Key word(s): Incoming Orders Vossloh receives another major order to supply rail fastening systems in China 08.05.2024 / 13:30 CET/CEST The issuer is solely responsible for the content of this announcement. Vossloh receives another major order to supply rail fastening systems in China Systems serve the construction of two high-speed lines The order is valued at the equivalent of around €40 million Deliveries planned from 2025 Werdohl, May 8, 2024. Vossloh has once again been awarded a contract to supply rail fastening systems in ...
EQS-News: Vossloh Aktiengesellschaft / Schlagwort(e): Auftragseingänge Vossloh erhält erneut Großauftrag zur Lieferung von Schienenbefestigungssystemen in China 08.05.2024 / 13:30 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Vossloh erhält erneut Großauftrag zur Lieferung von Schienenbefestigungssystemen in China Systeme dienen dem Bau von zwei Hochgeschwindigkeitsstrecken Auftragswert beträgt umgerechnet rund 40 Mio.€ Auslieferungen ab 2025 geplant Werdohl, 8. Mai 2024. Vossloh hat erneut den Zuschlag für die Lieferung von Sch...
Unifiedpost is a niche SaaS player in the e-invoicing and procurement channel space. Regulatory headwinds mean this market is ripe for growth, which should benefit Unifiedpost. Due to some unsuccessful past M&A, the company is in a challenging financial position today. However, it has recently embarked on a divestment path, aiming to streamline the business and improve its fundamentals. We like the new direction, however prefer to take a wait-and-see approach. - ...
Unifiedpost is a niche SaaS player in the e-invoicing and procurement channel space. Regulatory headwinds mean this market is ripe for growth, which should benefit Unifiedpost. Due to some unsuccessful past M&A, the company is in a challenging financial position today. However, it has recently embarked on a divestment path, aiming to streamline the business and improve its fundamentals. We like the new direction, however prefer to take a wait-and-see approach. - ...
On relatively flat H124 revenue, Claranova grew adjusted EBITDA more than 50% year-on-year as the focus on profitability over growth started to deliver. With Avanquest’s loss-making non-core business reducing, myDevices hitting break-even and customer acquisition costs back under control in PlanetArt, the company is better positioned to drive profitable growth. Management is targeting an adjusted EBITDA margin of c 10% in FY24. The company has refinanced its debt, providing funds to repay the OC...
>Ex disposals, Q1 results roughly in-line with expectations - Revenues in 24Q1 have fallen to $ 240.4m, down from $ 340m in 23Q1. Net revenues (after voyage expense) in 24Q1 have fallen to $ 203.5m (AAOB $ 197.9m) from $ 305.1m in 23Q1.EBITDA is reported at $ 550.5m but excluding disposal gain of $ 407.6m amounts to $ 142.9m (BB consensus $ 150m), down from $ 258.5m in 23Q1Net profit in 24Q1 has jumped to $ 495.0m (AAOB $ 492.6m) primarily thanks to the $ 40...
>Q3 2023/24 sales of € 94m (+4%, o/w +2% org), close to our forecasts - Claranova reported yesterday evening Q3 2023/24 sales of € 94m, up 4% year-on-year on a reported basis and 2% organically. This figure was close to our forecast (ODDO BHF: € 97m). By division, 1/ PlanetArt (65% of Q3 sales) reported a 2% organic decline. While this division is still not back on the organic growth path, sales have stabilised in the context of the priority given to profitability; 2/...
AB InBev: Busy BEES. Ahold Delhaize: Small beat, comforting confirmation of 2024 guidance. AMG: 1Q24 better than expected, FY guidance intact, strategic projects on schedule. Bekaert: Soft start to the year with 7% sales miss, FY guidance maintained. Euronav: Transformation at full speed. Marel: Another lacklustre quarter. Montea: 2025 guidance raised, valuations moving into positive territory. SBM Offshore: In-line Q1 trading update. Sif Group: Preview - normal quarter e...
Yesterday evening, Claranova reported Q3 FY24 revenue of EUR94m, up 4% as reported and 2% lfl. This was broadly in line with our expectations (EUR95m). The analysts' call also provided an opportunity for newly appointed CEO, Eric Gareau, to confirm that the strategic review announced last month was
>CA T3 2023/24 de 94 M€ (+4% dont +2% org), peu éloigné de nos attentes - Claranova a publié hier soir au titre du T3 2023/24 un CA de 94 M€, en hausse de 4% y-o-y en données publiées et de 2% en organique. Ce niveau d’activité ressort proche de nos attentes (ODDO BHF : 97 M€). En substance, 1/ PlanetArt (65% CA T3) affiche un repli de 2% org. Si la division n’a pas encore retrouvé le chemin de la croissance org., le niveau d’activité s’est stabilisé dans un contexte ...
SAVENCIA : actions et droits de vote - information mensuielle Actions et droits de vote – information mensuelle Au 31 mars 2024, le capital social se composait de 14 032 930 actions représentant un nombre total de droits de vote théoriques de 23 811 069 et un nombre total de droits de vote nets de 23 144 029. Pièce jointe
SAVENCIA : actions et droirs de vote - information mensuelle Actions et droits de vote – information mensuelle Au 30 avril 2024, le capital social se composait de 14 032 930 actions représentant un nombre total de droits de vote théoriques de 23 811 619 et un nombre total de droits de vote nets de 23 145 226. Pièce jointe
PARIS--(BUSINESS WIRE)-- Regulatory News: Claranova (Paris:CLA): Évolution du chiffre d’affaires par pôle d’activité sur le troisième trimestre de l’exercice 2023-2024 : En M€ Déc. 2023 à mars 2024 (3 mois) Déc. 2022 à mars 2023 (3 mois) Var. Var. à taux de change constants Var. à périmètre constant Var. à périm. et taux de change constants PlanetArt 61 60 2% -2% 2% -2% Avanquest 31 29 7% 8% 7% 8% myDevices 2 2 18% 18% ...
MARSEILLE, France--(BUSINESS WIRE)-- Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), today announced that the Company will hold a conference call on Tuesday, May 14, 2024, at 2 p.m. CEST / 8 a.m. EDT, to give an update on business progress during the first quarter of 2024. Participants during the call will be: Hervé Brailly, Chief Executive Officer Sonia Quaratino, Executive Vice President, Chief Medical Officer Yannis Morel, Executive Vice President, Chief Operating Officer Frédéric Lombard, Senior Vice President, Chief Financ...
MARSEILLE, France--(BUSINESS WIRE)-- Regulatory News: Innate Pharma SA (Euronext Paris : IPH ; Nasdaq : IPHA) (« Innate » ou la « Société ») a annoncé aujourd'hui qu'elle organisera une conférence téléphonique le mardi 14 mai 2024 à 14H00 CEST / 8h00 EDT afin de présenter ses résultats financiers et l’avancée de son portefeuille au premier trimestre 2024. La conférence sera animée par : Hervé Brailly, Président du Directoire Sonia Quaratino, Vice-président exécutif, Directeur Médical Yannis Morel, Vice-président exécutif, Directeur des Opérations Frédéric Lombard, Vice-présiden...
Virbac : Declaration of the number of shares and voting rights DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital(Article 223-16 of the General regulations of the French Financial Market Authority – Autoritédes Marchés Financiers) Quotation place: Euronext ParisCompartiment AISIN code: FR0000031577 DateTotal number of shares representing the share capitalTotal number of voting rightsApril, 30 20248 458 000Gross total of voting rights : 12 777 490Net total* of voting rights : 12 694 084 Net tot...
Virbac : Déclaration d'actions et de droits de vote 04/2024 DECLARATION D’ACTIONS ET DE DROITS DE VOTE Informations relatives au nombre total de droits de vote et au nombre d’actions composant le capital(Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) Place cotation : Euronext ParisCompartiment ACode ISIN : FR0000031577 DATENombre total d’actions composant le capital socialNombre total de droits de vote30 Avril 20248 458 000Total brut de droits de vote : 12 777 490Total net* de droits de vote : 12 694 084 Total net* = nombre total de droits de vote attachés au no...
PARIS--(BUSINESS WIRE)-- Regulatory News: Conformément aux articles L.233-8 II du Code de commerce et 223-16 du Règlement général de l’Autorité des Marchés Financiers, Claranova SE (ISIN : FR0013426004) (Paris:CLA) publie le nombre d’actions composant son capital social ainsi que le nombre de droits de vote associés au 30 avril 2024 : Actions composant le capital 57 206 910 Droits de vote théoriques (A) 57 206 910 Actions privées de droits de vote Auto détention au nominatif (B) 0 Auto détention au porteur (C) 473 787 ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.